Drug discovery hotspots: What is the secret to Switzerland’s success? (p1)
Drug Discovery World
JULY 2, 2024
Mazzetti and Schneider continue: “The transfer of technologies from the lab to the market, especially in the field of life sciences is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates, especially in the life sciences and biotherapeutics sector.
Let's personalize your content